New drug combo tested in tough blood cancers
NCT ID NCT04937166
Summary
This early-stage study tested a new drug called DSP107, given alongside standard chemotherapy drugs, for people with advanced forms of blood cancer (AML and MDS) that had come back or stopped responding to previous treatments. The main goals were to find a safe dose and see if the combination could help control the disease. The study was terminated after this initial phase.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
City of Hope
Duarte, California, 91010, United States
-
The University of Texas MD Anderson Cancer Center, Department of Leukemia
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.